What is Aoti?
Aoti is a privately-owned medical technology firm headquartered in Oceanside, California, USA, and Galway, Ireland. The company is dedicated to resolving severe and chronic wounds globally through its patented non-invasive Topical Wound Oxygen (TWO2) therapy. This advanced treatment aims to reduce healthcare expenditures and enhance the quality of life for individuals suffering from debilitating wound conditions. Aoti's technology is recognized for its efficacy in closing all types of chronic wounds.
How much funding has Aoti raised?
Aoti has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in Aoti
PPP
Public-Private Partnership
What's next for Aoti?
With the recent influx of capital and a total funding profile suggesting a late-stage development trajectory, Aoti is poised for accelerated growth and market expansion. The company's focus on innovative wound care solutions, particularly its TWO2 therapy, aligns with increasing healthcare demands for cost-effective and high-quality patient outcomes. Future strategic initiatives are likely to involve scaling production, broadening market penetration, and potentially further research and development to enhance its therapeutic offerings. The substantial investment signals strong investor confidence in Aoti's business model and its potential to disrupt the chronic wound care market.
See full Aoti company page
